rss
Emerg Med J 19:57-62 doi:10.1136/emj.19.1.57
  • Prehospital care

A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation

Table 3

Logistic regression analysis of possible factors contributing to the primary end point: (ROSC at the scene or in A&E)

Odds ratio (95% CI) p
Age 0.56
    An increase of 1 year 1.01 (0.97 to 1.07)
Witnessed arrest 0.87
    Witnessed 1.00
    Unwitnessed 0.56 (0.06 to 4.97)
    Unknown 0.93 (0.09 to 9.77)
Bystander CPR 0.23
    Good 1.00
    Poor/none 0.48 (0.14 to 1.61)
    Unknown 0.56 (0.23 to 1.72)
Response time 0.10
    An increase of 1 minute 0.89 (0.77 to 1.02)
Received magnesium 0.37
    Placebo 1.00
    Magnesium 1.69 (0.54 to 5.30)
Amount of magnesium given 0.51
    2 g (8 mmol) 1.00
    4 g (16 mmol) 1.74 (0.37 to 8.14)
    Placebo 0.77 (0.19 to 3.11)

This Article

Blogs and podcasts

Blogs and podcasts

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EMJ.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.